ALSMA Stock Overview
S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
S.M.A.I.O S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €3.18 |
52 Week High | €3.98 |
52 Week Low | €1.90 |
Beta | 0.48 |
1 Month Change | 1.27% |
3 Month Change | 7.43% |
1 Year Change | -6.47% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -42.91% |
Recent News & Updates
Recent updates
Shareholder Returns
ALSMA | FR Medical Equipment | FR Market | |
---|---|---|---|
7D | 1.3% | -0.08% | -0.2% |
1Y | -6.5% | 16.8% | 2.3% |
Return vs Industry: ALSMA underperformed the French Medical Equipment industry which returned 17.1% over the past year.
Return vs Market: ALSMA underperformed the French Market which returned 2.9% over the past year.
Price Volatility
ALSMA volatility | |
---|---|
ALSMA Average Weekly Movement | 7.9% |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 4.5% |
10% most volatile stocks in FR Market | 9.8% |
10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: ALSMA has not had significant price volatility in the past 3 months.
Volatility Over Time: ALSMA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 38 | Philippe Roussouly | smaio.com |
S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. The company was incorporated in 2009 and is based in Saint-Priest, France.
S.M.A.I.O S.A. Fundamentals Summary
ALSMA fundamental statistics | |
---|---|
Market cap | €16.63m |
Earnings (TTM) | -€902.77k |
Revenue (TTM) | €6.91m |
2.4x
P/S Ratio-18.4x
P/E RatioIs ALSMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALSMA income statement (TTM) | |
---|---|
Revenue | €6.91m |
Cost of Revenue | €3.05m |
Gross Profit | €3.86m |
Other Expenses | €4.76m |
Earnings | -€902.77k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Oct 15, 2024
Earnings per share (EPS) | -0.17 |
Gross Margin | 55.85% |
Net Profit Margin | -13.06% |
Debt/Equity Ratio | 14.7% |
How did ALSMA perform over the long term?
See historical performance and comparison